Up a level |
Orrell, C, Kintu, K, Coombs, JA, Amara, A, Myer, L, Kaboggoza, J ORCID: 0000-0001-9510-0474, Simmons, B, Else, L, Heiberg, C, Waitt, C et al (show 6 more authors)
(2018)
DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy.
.
Dickinson, Laura ORCID: 0000-0001-5557-9396, Walimbwa, Stephen, Singh, Yashna, Kaboggoza, Julian, Kintu, Kenneth, Sihlangu, Mary, Coombs, Julie-Anne, Malaba, Thokozile R, Byamugisha, Josaphat, Pertinez, Henry et al (show 12 more authors)
(2021)
Infant Exposure to Dolutegravir Through Placental and Breast Milk Transfer: A Population Pharmacokinetic Analysis of DolPHIN-1.
CLINICAL INFECTIOUS DISEASES, 73 (5).
E1200 - E1207.